| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:10:11 UTC |
|---|
| Update date | 2020-09-17 15:31:13 UTC |
|---|
| Primary ID | FDB012462 |
|---|
| Secondary Accession Numbers | |
|---|
| Chemical Information |
|---|
| FooDB Name | alpha-Linolenic acid |
|---|
| Description | alpha-Linolenic acid (ALA) is a polyunsaturated fatty acid (PUFA). It is a member of the group of essential fatty acids called omega-3 fatty acids. alpha-Linolenic acid is not synthesized by mammals and therefore is an essential dietary requirement for all mammals. Omega-3 fatty acids get their name based on the location of one of their first double bonds. In all omega-3 fatty acids, the first double bond is located between the third and fourth carbon atom counting from the methyl end of the fatty acid (n-3). Although humans and other mammals can synthesize saturated and some monounsaturated fatty acids from carbon groups in carbohydrates and proteins, they lack the enzymes necessary to insert a cis double bond at the n-6 or the n-3 position of a fatty acid. Certain nuts (English walnuts) and vegetable oils (canola, soybean, flaxseed/linseed, olive) are rich in alpha-linolenic acid. Omega-3 fatty acids like alpha-linolenic acid are important structural components of cell membranes. When incorporated into phospholipids, they affect cell membrane properties such as fluidity, flexibility, permeability, and the activity of membrane-bound enzymes. Omega-3 fatty acids can modulate the expression of several genes, including those involved with fatty acid metabolism and inflammation. alpha-Linolenic acid and other omega-3 fatty acids may regulate gene expression by interacting with specific transcription factors, including peroxisome proliferator-activated receptors (PPARs) and liver X receptors (LXRs). alpha-Linolenic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism. Patients with isovaleric acidemia have a defect in leucine catabolism resulting from a deficiency in the enzyme isovaleryl-CoA dehydrogenase. These patients do well on a low protein/low leucine diet but a low protein diet can lead to deficiencies in essential fatty acids, such as alpha-linolenic acid ( https://doi.org/10.1038/ejcn.2016.100). |
|---|
| CAS Number | 463-40-1 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| (9,12,15)-Linolenic acid | ChEBI | | (9Z,12Z,15Z)-Octadecatrienoic acid | ChEBI | | (Z,Z,Z)-9,12,15-Octadecatrienoic acid | ChEBI | | 9,12,15-Octadecatrienoic acid | ChEBI | | 9-cis,12-cis,15-cis-Octadecatrienoic acid | ChEBI | | ALA | ChEBI | | all-cis-9,12,15-Octadecatrienoic acid | ChEBI | | cis,cis,cis-9,12,15-Octadecatrienoic acid | ChEBI | | cis-Delta(9,12,15)-Octadecatrienoic acid | ChEBI | | Linolenic acid | ChEBI | | Linolenate | Kegg | | alpha-Linolenate | Kegg | | (9,12,15)-Linolenate | Generator | | (9Z,12Z,15Z)-Octadecatrienoate | Generator | | (Z,Z,Z)-9,12,15-Octadecatrienoate | Generator | | 9,12,15-Octadecatrienoate | Generator | | 9-cis,12-cis,15-cis-Octadecatrienoate | Generator | | all-cis-9,12,15-Octadecatrienoate | Generator | | cis,cis,cis-9,12,15-Octadecatrienoate | Generator | | cis-delta(9,12,15)-Octadecatrienoate | Generator | | cis-Δ(9,12,15)-octadecatrienoate | Generator | | cis-Δ(9,12,15)-octadecatrienoic acid | Generator | | a-Linolenate | Generator | | a-Linolenic acid | Generator | | Α-linolenate | Generator | | Α-linolenic acid | Generator | | alpha Linolenic acid | MeSH | | cis-9,12,15-Octadecatrienoate | HMDB | | cis-9,12,15-Octadecatrienoic acid | HMDB | | Industrene 120 | HMDB | | FA(18:3(9Z,12Z,15Z)) | HMDB | | FA(18:3n3) | HMDB | | α-Linolenic acid | biospider | | 9,12,15-Octadecatrienoic acid, (Z,Z,Z)- | biospider | | 9Z,12Z,15Z-Octadecatrienoate | biospider | | 9Z,12Z,15Z-Octadecatrienoic acid | biospider | | alpha-Linolenic acid | biospider | | cis-δ(9,12,15)-octadecatrienoate | Generator | | cis-δ(9,12,15)-octadecatrienoic acid | Generator | | α-linolenate | Generator | | α-linolenic acid | Generator |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C18H30O2 |
|---|
| IUPAC name | (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid |
|---|
| InChI Identifier | InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9- |
|---|
| InChI Key | DTOSIQBPPRVQHS-PDBXOOCHSA-N |
|---|
| Isomeric SMILES | CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O |
|---|
| Average Molecular Weight | 278.4296 |
|---|
| Monoisotopic Molecular Weight | 278.224580204 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Lineolic acids and derivatives |
|---|
| Direct Parent | Lineolic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Octadecanoid
- Long-chain fatty acid
- Fatty acid
- Unsaturated fatty acid
- Straight chain fatty acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Process | Naturally occurring process: |
|---|
| Role | Industrial application: Biological role: |
|---|
| Foods | Nuts and legumes: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Liquid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 77.65%; H 10.86%; O 11.49% | DFC |
|---|
| Melting Point | Mp -11.3° | DFC |
|---|
| Boiling Point | Bp0.05 125° | DFC |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | 6.46 | SANGSTER (1993) |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | d204 0.92 | DFC |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| GC-MS | alpha-Linolenic acid, 1 TMS, GC-MS Spectrum | splash10-052f-7900000000-8765cf82603feb1b448f | Spectrum | | GC-MS | alpha-Linolenic acid, 1 TMS, GC-MS Spectrum | splash10-004i-9300000000-302519a616eaed5fcc59 | Spectrum | | GC-MS | alpha-Linolenic acid, 1 TMS, GC-MS Spectrum | splash10-005c-9800000000-2d44b3c70e2992b9a812 | Spectrum | | GC-MS | alpha-Linolenic acid, non-derivatized, GC-MS Spectrum | splash10-052f-7900000000-8765cf82603feb1b448f | Spectrum | | GC-MS | alpha-Linolenic acid, non-derivatized, GC-MS Spectrum | splash10-004i-9300000000-302519a616eaed5fcc59 | Spectrum | | GC-MS | alpha-Linolenic acid, non-derivatized, GC-MS Spectrum | splash10-005c-9800000000-2d44b3c70e2992b9a812 | Spectrum | | GC-MS | alpha-Linolenic acid, non-derivatized, GC-MS Spectrum | splash10-052f-5900000000-28710ea35f196c595e03 | Spectrum | | Predicted GC-MS | alpha-Linolenic acid, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-052e-6950000000-27037263e74c8119ead0 | Spectrum | | Predicted GC-MS | alpha-Linolenic acid, 1 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-00ds-6931000000-657fa0cc66a206a36409 | Spectrum | | Predicted GC-MS | alpha-Linolenic acid, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, N/A (Annotated) | splash10-004i-0190000000-aee97e9ea2c7f0783adf | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, N/A (Annotated) | splash10-05nb-9500000000-fb92aefc701027239359 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, N/A (Annotated) | splash10-0aru-9100000000-a5dddfe6f629d1371fac | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-004i-0090000000-2b7bea03a685454dd135 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF , Negative | splash10-004i-0090000000-53ddfaed6ce13c37d957 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-004i-0090000000-e5350a66361bc63d1071 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 30V, Negative | splash10-004i-0090000000-5731aa5e301022c06813 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-004i-0091010000-6922411e48d747e592b5 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-IT , negative | splash10-001i-0090000000-a18b573ad888d048efa6 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-004i-0090000000-2b7bea03a685454dd135 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-004i-0090000000-e5350a66361bc63d1071 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-004i-0090000000-5731aa5e301022c06813 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF 10V, positive | splash10-004i-0090000000-1d391027db3704d71cb9 | 2020-07-21 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF 20V, positive | splash10-00lr-9210000000-41acd8a55f52afec6d79 | 2020-07-21 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF 40V, positive | splash10-014i-9000000000-a976b4a80a07eb2c4641 | 2020-07-21 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-0a4i-9100000000-497eddf5d738a45f83fb | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0090000000-0c00ca98901526cb2e26 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 30V, Negative | splash10-004i-1090000000-35ffce9343fe0d15ea0d | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 30V, Negative | splash10-004i-0090000000-373584fbab950d6676cc | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-01t9-0090000000-ae1f482177d0e208165e | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00o0-5690000000-20804c8382f14ff0ccf4 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-014l-8930000000-9d5e342b1351adc71c20 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0090000000-4d3e8d1180800a7b4ed5 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0059-1090000000-67ab14c068a142dd3c30 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-9230000000-403c610d63380e63109a | 2017-07-26 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, H2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 4444437 |
|---|
| ChEMBL ID | CHEMBL8739 |
|---|
| KEGG Compound ID | C06427 |
|---|
| Pubchem Compound ID | 5280934 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 27432 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB00132 |
|---|
| HMDB ID | HMDB01388 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | CPM16-L:HHB80-W |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | CIS-LINOLEIC-ACID|ALPHA-LINOLENIC-ACID|LINOLENIC-ACID |
|---|
| BIGG ID | 48237 |
|---|
| KNApSAcK ID | C00007247 |
|---|
| HET ID | LNL |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | rw1045911 |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Alpha-Linolenic_acid |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| 5-alpha-reductase inhibitor | 50781 | An agent that blocks the conversion of testosterone to dihydrotestosterone, reducing androgenic effects. Therapeutically, it treats benign prostatic hyperplasia, androgenetic alopecia, and acne, by decreasing prostate size, promoting hair growth, and minimizing sebaceous gland activity. | DUKE | | Anti-aggregant | | An agent that prevents platelet aggregation, reducing blood clot formation. Its biological role is to inhibit platelet activation, and its therapeutic applications include preventing thrombosis and stroke. Key medical uses include treating cardiovascular diseases, such as myocardial infarction and atrial fibrillation, and managing conditions that increase the risk of blood clots. | DUKE | | Anti hypertensive | 52217 | An agent that lowers blood pressure, reducing the risk of cardiovascular disease. It plays a biological role in relaxing blood vessels, decreasing cardiac workload, and improving blood flow. Therapeutically, it's used to manage hypertension, heart failure, and stroke, with key medical applications in preventing organ damage and improving overall cardiovascular health. | DUKE | | Anti-inflammatory | 35472 | An agent that reduces inflammation, playing a biological role in suppressing immune responses and therapeutic applications in managing pain, swelling, and redness. Key medical uses include treating arthritis, allergies, and autoimmune disorders, as well as relieving symptoms of conditions such as asthma and dermatitis. | DUKE | | Anti leukotriene-D4 | 35222 | An agent that blocks the action of leukotriene D4, reducing inflammation and bronchoconstriction. Therapeutically, it's used to treat asthma, allergic rhinitis, and other respiratory disorders by inhibiting leukotriene-mediated responses, providing relief from symptoms such as wheezing, coughing, and shortness of breath. | DUKE | | Anti-menorrhagic | 52217 | An agent that reduces heavy menstrual bleeding, playing a biological role in regulating menstrual flow. Therapeutically, it is used to treat menorrhagia, with key medical applications including managing excessive uterine bleeding, dysmenorrhea, and menstrual disorders. | DUKE | | Anti metastatic | 35610 | An agent that inhibits cancer cell spread, reducing tumor metastasis. It plays a biological role in blocking cell migration and invasion, and has therapeutic applications in cancer treatment. Key medical uses include preventing cancer recurrence and improving survival rates in patients with various types of cancer. | DUKE | | Anti-prostatitic | | An agent that relieves prostatitis, reducing inflammation of the prostate gland, and is used to treat benign prostatic hyperplasia (BPH) and chronic pelvic pain syndrome. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Hypotensive | | An agent that lowers blood pressure, playing a biological role in regulating cardiovascular function. Therapeutically, it's used to manage hypertension, heart failure, and angina, with key medical applications in preventing stroke, kidney disease, and cardiac complications. | DUKE | | Immunostimulant | 50847 | An agent that stimulates the immune system, enhancing its response to infections and diseases. Therapeutically, it boosts the body's natural defenses, commonly used to treat immunodeficiency disorders, prevent infections, and support cancer treatment, as well as manage chronic conditions like hepatitis and HIV. | DUKE | | Lymphocytogenic | | An agent that stimulates production of lymphocytes, enhancing immune response. Therapeutically, it promotes lymphocyte growth, aiding in cancer treatment and immune system disorders. Key medical uses include immunotherapy and treating lymphopenia, or low lymphocyte count, to boost the body's natural defense mechanisms. | DUKE | | Tyrosine kinase inhibitor | | An agent that blocks the enzymatic activity of tyrosine kinases, enzymes responsible for the activation of many proteins involved in signal transduction pathways regulating cell growth and survival. Therapeutically, tyrosine kinase inhibitors are widely used in the treatment of various cancers and proliferative diseases, by halting aberrant signaling that drives tumor progression and pathological tissue remodeling. | DUKE | | Prostaglandin synthesis inhibitor | 35222 | An agent that blocks the production of prostaglandins, reducing inflammation and pain. Therapeutically, it's used to treat conditions like arthritis, menstrual cramps, and fever, commonly found in nonsteroidal anti-inflammatory drugs (NSAIDs). | DUKE | | Vasodilator | 35620 | An agent that widens blood vessels, reducing blood pressure and increasing blood flow. It plays a biological role in regulating cardiovascular function. Therapeutically, vasodilators are used to treat conditions such as hypertension, angina, and heart failure, improving oxygen delivery and reducing cardiac workload. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Bile acid-CoA:amino acid N-acyltransferase | BAAT | Q14032 | | Cytosolic acyl coenzyme A thioester hydrolase | ACOT7 | O00154 | | Acyl-coenzyme A thioesterase 2, mitochondrial | ACOT2 | P49753 | | Acyl-coenzyme A thioesterase 4 | ACOT4 | Q8N9L9 | | Acyl-coenzyme A thioesterase 8 | ACOT8 | O14734 | | Acyl-coenzyme A thioesterase 1 | ACOT1 | Q86TX2 | | Elongation of very long chain fatty acids protein 4 | ELOVL4 | Q9GZR5 |
|
|---|
| Pathways | | Name | SMPDB Link | KEGG Link |
|---|
| Alpha Linolenic Acid and Linoleic Acid Metabolism | SMP00018 | map00592 |
|
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| faint |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | fatty |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | bitter |
- Ayana Wiener, Marina Shudler, Anat Levit, Masha Y. Niv. BitterDB: a database of bitter compounds. Nucleic Acids Res 2012, 40(Database issue):D413-419. DOI:10.1093/nar/gkr755
|
|
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Saxholt, E., et al. 'Danish food composition databank, revision 7.' Department of Nutrition, National Food Institute, Technical University of Denmark (2008). — U.S. Department of Agriculture, Agricultural Research Service. 2008. USDA National Nutrient Database for Standard Reference, Release 21. Nutrient Data Laboratory Home Page. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|